CN108447568A - Medication information processing method based on drug ingredient - Google Patents
Medication information processing method based on drug ingredient Download PDFInfo
- Publication number
- CN108447568A CN108447568A CN201810224999.6A CN201810224999A CN108447568A CN 108447568 A CN108447568 A CN 108447568A CN 201810224999 A CN201810224999 A CN 201810224999A CN 108447568 A CN108447568 A CN 108447568A
- Authority
- CN
- China
- Prior art keywords
- information
- drug
- medication
- rule
- ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention relates to a kind of medication information processing method based on drug ingredient, including：Step 1, classifying drugs information and drug ingredient information are obtained；Step 2, drug ingedient classified catalogue is generated according to the classifying drugs information and drug ingredient information；Step 3, the drug ingredient information and rational use of medicines rule are established into incidence relation in the drug ingedient classified catalogue；Step 4, doctor's advice information is received, medication information and patient characteristic information are extracted from the doctor's advice information；Step 5, the corresponding medication composition information of the medication information is inquired in the drug ingedient classified catalogue；Step 6, judge whether the medication composition information meets the rational use of medicines rule according to the patient characteristic information；Step 7, if it is not, then generating information warning is sent to terminal device.
Description
Technical field
The present invention relates to technical field of data processing more particularly to a kind of medication information processing sides based on drug ingredient
Method.
Background technology
In recent years, Prescription automatic screening system can quickly and more generally most of clinical application be unreasonable asks for reflection
Topic realizes that the medication between " drug-drug " examines, such as interaction between drug, repeated drug taking, incompatibility can be from
Problem is reacted in general orientation, but since existing Pharmacologic classifications directory scheme mostly uses greatly anatomy acology and chemistry
(Anatomical Therapeutic Chemical, ATC) sorting technique, intricate and compactness the pass of the classification
Connection so that there are certain deviation and inaccuracies in medication selection for some drugs, compare flexible clinical practice reasonability
Using there are certain inadaptabilities.Such as：To the control of certain composition " sharing dosage " between realization medication, still have some deficits
Place.
Currently, being badly in need of a kind of for the more careful accurately solution being monitored with the reasonability of explosive component.
Invention content
The purpose of the present invention is in view of the deficiencies in the prior art, provide a kind of medication information based on drug ingredient
Processing method.
To achieve the above object, the present invention provides a kind of medication information processing method based on drug ingredient, including：
Step 1, classifying drugs information and drug ingredient information are obtained；
Step 2, drug ingedient classified catalogue is generated according to the classifying drugs information and drug ingredient information；
Step 3, the drug ingredient information and rational use of medicines rule are established in the drug ingedient classified catalogue and is closed
Connection relationship；
Step 4, doctor's advice information is received, medication information and patient characteristic information are extracted from the doctor's advice information；
Step 5, the corresponding medication composition information of the medication information is inquired in the drug ingedient classified catalogue；
Step 6, judge whether the medication composition information meets the rational use of medicines and advise according to the patient characteristic information
Then；
Step 7, if it is not, then generating information warning is sent to terminal device.
Further, the medication information specifically includes：Nomenclature of drug information and pharmaceutical formulation information.
Further, described that the corresponding medication ingredient letter of the medication information is inquired in the drug ingedient classified catalogue
Breath specifically includes：
Inquired in the drug ingedient classified catalogue the corresponding medication Components Name of the medication information, fractional value and
Unit.
Further, the patient characteristic information specifically includes：
Patient height's feature, weight feature, age characteristics, sex character, drug anaphylaxis information, vital sign/bosom
Pregnant/lactation/puerpera's feature.
Further, it is described according to the patient characteristic information judge the medication composition information whether meet it is described rationally
Medication rule specifically includes：
Select the corresponding rational use of medicines rule of the patient characteristic information；
Judge whether the medication composition information meets the corresponding rational use of medicines rule of the patient characteristic information.
Further, the rational use of medicines rule specifically includes：Drug anaphylaxis rule, drug drug interaction/weight
It is multiplexed medicine rule, dosage control rule.
Further, the drug ingedient classified catalogue includes medicine information；The method further includes：By medicine information with
Drug ingredient information establishes mapping relations.
Further, after step 7, the method further includes：
Store the information warning；
It is generated according to the information warning and judges the unreasonable case medical data collection of medication based on medication components.
Medication information processing method provided by the invention based on drug ingredient, according to classifying drugs information and drug ingredient
Information generates drug ingedient classified catalogue, is associated with drug ingredient information with medicine information foundation in drug ingedient classified catalogue
Relationship, and by the suggestion and application of rational use of medicines rule, by the medication information in doctor's advice information according in rational use of medicines rule
Drug ingredient decision logic carries out Rationality Assessment, is more bonded the pharmacodynamics and dynamic metabolism concept of drug so that between drug
Dosage, interaction, repeated drug taking, related drugs merge using problem examination position it is more careful with it is accurate.
Description of the drawings
Fig. 1 is the medication information processing method flow chart provided in an embodiment of the present invention based on drug ingredient；
Fig. 2 is drug ingedient classified catalogue schematic diagram provided in an embodiment of the present invention；
Fig. 3 is medicine information provided in an embodiment of the present invention and drug ingredient information MAP relation schematic diagram；
Fig. 4 is medicine information provided in an embodiment of the present invention and drug ingredient maintenance of information interface schematic diagram.
Specific implementation mode
Below by drawings and examples, technical scheme of the present invention will be described in further detail.
Rational use of medicines rule in technical solution of the present invention derives from knowledge of rational drug use library, and knowledge of rational drug use library is established
Safely, effectively, economic medication purpose on the basis of, be to be based on specification, clinical application is it should be clear that and various international and country doctor
The independent knowledge library that authority's safe medication guide such as medicine regulation is formed.
Sentenced automatically using the form of intelligent logical reasoning using intelligent inference engine technique in knowledge of rational drug use library
The legitimate result of disconnected medication.Its essence is a series of logical consequence preset rules, then according to actual medication object and number
According to, progress logic judgment, and according to the reasoning process in knowledge base, constantly derive, until obtaining final result.
Fig. 1 be the present embodiments relate to the medication information processing method flow chart based on drug ingredient.Such as Fig. 1 institutes
Show, specifically comprises the following steps：
Step 101, classifying drugs information and drug ingredient information are obtained；
It is called in medicine information database and meets preset condition medicine information, including classifying drugs information and drug ingredient
Information.
Step 102, drug ingedient classified catalogue is generated according to classifying drugs information and drug ingredient information；
Using the pharmacological action of drug as the important reference of writing, using drug composition identified in drug at
Point, it is written as the drug ingedient directory tree for being associated with and showing with tree structure.
In a specific embodiment, the drug ingedient classified catalogue of foundation is as shown in Figure 2.
The logic that composition directory tree and Ingredient Dictionary value form close relation is whole, composition directory tree and Ingredient Dictionary value it
Between there is corresponding association and logic inheritance, and dictionary value can be carried out to Ingredient Dictionary value according to the scientific development of application
Increase or the adjustment of logical construction.
In addition, drug ingedient classified catalogue further includes medicine information；Medicine information and drug ingredient information are established and mapped
Relationship, medicine information and the interface schematic diagram of drug ingredient information MAP relationship are as shown in Figure 3.Fig. 4 carries for the embodiment of the present invention
The medicine information of confession and drug ingredient maintenance of information interface schematic diagram.
Step 103, drug ingredient information and rational use of medicines rule are established into incidence relation in drug ingedient classified catalogue；
Wherein, rational use of medicines rule specifically includes：Drug anaphylaxis rule, uses medicament at drug drug interaction rule
Amount control rule etc..
The purpose that drug ingredient information and rational use of medicines rule are established to incidence relation is can by drug ingredient information
Corresponding rational use of medicines rule is inquired, as the basis for carrying out medication reasonability judgement subsequently through drug ingredient information.
Step 104, doctor's advice information is received, medication information and patient characteristic information are extracted from doctor's advice information；
Wherein, medication information specifically includes：Nomenclature of drug information and pharmaceutical formulation information etc..Patient characteristic information is specifically wrapped
It includes：Patient height's feature, weight feature, age characteristics, sex character, drug anaphylaxis information, vital sign/pregnancy/food in one's mouth
Breast/puerpera's feature etc..
Step 105, the corresponding medication composition information of medication information is inquired in drug ingedient classified catalogue；
Specifically, inquired in drug ingedient classified catalogue the corresponding medication Components Name of medication information, fractional value and
Unit.
Step 106, judge whether medication composition information meets rational use of medicines rule according to patient characteristic information；
Specifically, the corresponding rational use of medicines rule of selection patient characteristic information；Judge whether medication composition information meets trouble
The corresponding drug anaphylaxis rule of person's characteristic information, drug drug interaction/repeated drug taking rule, dosage control rule
Equal rational uses of medicines rule.
Step 107, if it is not, then generating information warning is sent to terminal device.
If the medication composition information in doctor's advice information do not meet the rational use of medicines rule, can in the form of information warning
The terminal device of doctor terminal, nurse end and pharmacist end carries out medication intervention, while storing these information warnings, is formed and is based on drug
Composition judges the unreasonable case medical data collection of medication, is used for retrospection appraisal.
Medication information processing method provided by the invention based on drug ingredient, according to classifying drugs information and drug ingredient
Information generates drug ingedient classified catalogue, is associated with drug ingredient information with medicine information foundation in drug ingedient classified catalogue
Relationship, and by the suggestion and application of rational use of medicines rule, by the medication information in doctor's advice information according in rational use of medicines rule
Drug ingredient decision logic carries out Rationality Assessment, is more bonded the pharmacodynamics and dynamic metabolism concept of drug so that between drug
Dosage, interaction, repeated drug taking, related drugs merge using problem examination position it is more careful with it is accurate.
It is the specific embodiment that medication reasonability judgement is carried out using technical solution of the present invention below：
1, drug anaphylaxis related embodiment
Anaphylactogen selects, and quotes composition catalogue, anaphylactogen control is carried out by ingredient, if a certain composition is in used drug
Middle presence then can pop up information warning when doctor issues doctor's advice in not used drug there are when the ingredient.
Certain patient is to this composition allergy of aspirin, and similarly, the patient is for the drug containing aspirin component
Same allergy, in spite of allergic reaction had occurred, such as when doctor issues the drug containing this composition：Ah coffee's phenol, Ah Si wait for
When the preparations such as cause, Aminodyne Compound, aluminium, system will warn doctor, and the patient is to the drug currently issued
Present in composition aspirin-sensitive.
If going to realize with drug selection, need that the drug comprising this composition is included in selection one by one in rule, and hold
Leakiness selects, but composition is selected to realize, as long as all relevant drugs, can be included by this composition of selection aspirin,
Realize that the more accurately rational use of medicines monitors.
2, the interaction related embodiment between drug
Interaction between drug, mainly ingredient and be divided between interaction, when general medication can prompt with
It is careful to be needed when drug combination containing certain ingredient.
【Medicine name】Diclofenac sodium extended action tablet
【Drug interaction】C14H10Cl2NNaO2 can increase the plasma concentration of digoxin and the preparation containing lithium, reduce kidney to ammonia first
The excretion of petrin.It therefore, should especially with caution when being shared with these medicines.
When doctor issues C14H10Cl2NNaO2 drug, while issuing containing digoxin, preparation containing lithium, methotrexate composition
When drug, system will warn, and there is interaction when two medicines share.
3, the control related embodiment of drug medication dosage
【Medicine name】Valsartan amlodipine piece
【Specification】Every 80mg containing Valsartan, Amlodipine 5mg.
【Usage and dosage】2.5mg to 10mg is effective for treatment hypertension once a day for Amlodipine, and Valsartan is effective
Dosage is 80mg to 320mg.In the clinical test of the treatment of valsartan amlodipine piece once a day, the ammonia of 5mg-10mg is used
The Valsartan of Flordipine and 80mg-320mg, efficacy of antihypertensive treatment increase as dosage increases.
In clinical application, it can be needed to carry out oligomict increase according to illness, but the medication limitation of total ingredient cannot surpass
When crossing the ingredient maximum daily dose, temporarily can not accurately it be managed by current classification of drug catalogue.
Doctor's evolution：2 tablet per day of valsartan amlodipine piece；Valsartan capsule 320mg/ days.
Medication reasonability judgment rule is as follows：
Rule of judgment 1：The daily dosage of Valsartan oral dose is no more than 320mg；
Rule of judgment 2：The daily dosage of Amlodipine oral dose is no more than 10mg；
Irrational Use of Drugs problem 1 is examined according to doctor's advice：The daily dosage of Valsartan is unreasonable.
2.5mg to 10mg is effective for treatment hypertension once a day for Amlodipine, and what which was issued uses effective prescription
Middle Amlodipine dosage is equal to and is less than 10mg, should be judged as that medication is reasonable.
Professional should further appreciate that, described in conjunction with the examples disclosed in the embodiments of the present disclosure
Unit and algorithm steps, can be realized with electronic hardware, computer software, or a combination of the two, hard in order to clearly demonstrate
The interchangeability of part and software generally describes each exemplary composition and step according to function in the above description.
These functions are implemented in hardware or software actually, depend on the specific application and design constraint of technical solution.
Professional technician can use different methods to achieve the described function each specific application, but this realization
It should not be considered as beyond the scope of the present invention.
The step of method described in conjunction with the examples disclosed in this document or algorithm, can use hardware, processor to execute
The combination of software module or the two is implemented.Software module can be placed in random access memory (RAM), memory, read-only memory
(ROM), electrically programmable ROM, electrically erasable ROM, register, hard disk, moveable magnetic disc, CD-ROM or technical field
In any other form of storage medium well known to interior.
Above-described specific implementation mode has carried out further the purpose of the present invention, technical solution and advantageous effect
It is described in detail, it should be understood that the foregoing is merely the specific implementation mode of the present invention, is not intended to limit the present invention
Protection domain, all within the spirits and principles of the present invention, any modification, equivalent substitution, improvement and etc. done should all include
Within protection scope of the present invention.
Claims (8)
1. a kind of medication information processing method based on drug ingredient, which is characterized in that the method includes：
Step 1, classifying drugs information and drug ingredient information are obtained；
Step 2, drug ingedient classified catalogue is generated according to the classifying drugs information and drug ingredient information；
Step 3, the drug ingredient information is associated with pass with the foundation of rational use of medicines rule in the drug ingedient classified catalogue
System；
Step 4, doctor's advice information is received, medication information and patient characteristic information are extracted from the doctor's advice information；
Step 5, the corresponding medication composition information of the medication information is inquired in the drug ingedient classified catalogue；
Step 6, judge whether the medication composition information meets the rational use of medicines rule according to the patient characteristic information；
Step 7, if it is not, then generating information warning is sent to terminal device.
2. according to the method described in claim 1, it is characterized in that, the medication information specifically includes：Nomenclature of drug information and
Pharmaceutical formulation information.
3. according to the method described in claim 1, it is characterized in that, it is described in the drug ingedient classified catalogue inquiry described in
The corresponding medication composition information of medication information specifically includes：
The corresponding medication Components Name of the medication information, fractional value and list are inquired in the drug ingedient classified catalogue
Position.
4. according to the method described in claim 1, it is characterized in that, the patient characteristic information specifically includes：
Patient height's feature, weight feature, age characteristics, sex character, drug anaphylaxis information, vital sign/pregnancy/food in one's mouth
Breast/puerpera's feature.
5. according to the method described in claim 1, it is characterized in that, described judge the medication according to the patient characteristic information
Whether composition information, which meets the rational use of medicines rule, specifically includes：
Select the corresponding rational use of medicines rule of the patient characteristic information；
Judge whether the medication composition information meets the corresponding rational use of medicines rule of the patient characteristic information.
6. method according to claim 1 or 5, which is characterized in that the rational use of medicines rule specifically includes：Drug allergy
Response rule, drug drug interaction/repeated drug taking rule, dosage control rule.
7. according to the method described in claim 1, it is characterized in that, the drug ingedient classified catalogue includes medicine information；Institute
The method of stating further includes：Medicine information and drug ingredient information are established into mapping relations.
8. according to the method described in claim 1, it is characterized in that, after step 7, the method further includes：
Store the information warning；
It is generated according to the information warning and judges the unreasonable case medical data collection of medication based on medication components.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810224999.6A CN108447568A (en) | 2018-03-19 | 2018-03-19 | Medication information processing method based on drug ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810224999.6A CN108447568A (en) | 2018-03-19 | 2018-03-19 | Medication information processing method based on drug ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108447568A true CN108447568A (en) | 2018-08-24 |
Family
ID=63195129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810224999.6A Pending CN108447568A (en) | 2018-03-19 | 2018-03-19 | Medication information processing method based on drug ingredient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108447568A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109065118A (en) * | 2018-09-26 | 2018-12-21 | 平安科技（深圳）有限公司 | A kind of medical data processing method, device, terminal and readable storage medium storing program for executing |
| CN110767320A (en) * | 2019-10-31 | 2020-02-07 | 北京东软望海科技有限公司 | Data processing method and device, electronic equipment and readable storage medium |
| CN112116976A (en) * | 2019-06-20 | 2020-12-22 | 上海智臻智能网络科技股份有限公司 | Method and device for processing medicine information and computer readable storage medium |
| CN112164441A (en) * | 2020-10-07 | 2021-01-01 | 上海常笑健康咨询服务有限公司 | Internet-based online real-time total parenteral nutrition prescription rationality optimization system |
| CN113012782A (en) * | 2021-03-05 | 2021-06-22 | 中国医学科学院阜外医院 | Method and device for recommending medicine |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050149362A1 (en) * | 2003-12-30 | 2005-07-07 | Peterson Per A. | System and method for visually presenting digital patient information for future drug use resulting from dosage alteration |
| CN104584021A (en) * | 2014-11-07 | 2015-04-29 | 曹庆恒 | Method, system and device for intelligently selecting medicine |
| CN107180157A (en) * | 2017-05-11 | 2017-09-19 | 杭州逸曜信息技术有限公司 | Medical information processing method |
| CN107341345A (en) * | 2017-06-22 | 2017-11-10 | 厦门大学 | A kind of clinical rational drug use methods of risk assessment based on electronic health record big data |
-
2018
- 2018-03-19 CN CN201810224999.6A patent/CN108447568A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050149362A1 (en) * | 2003-12-30 | 2005-07-07 | Peterson Per A. | System and method for visually presenting digital patient information for future drug use resulting from dosage alteration |
| CN104584021A (en) * | 2014-11-07 | 2015-04-29 | 曹庆恒 | Method, system and device for intelligently selecting medicine |
| CN107180157A (en) * | 2017-05-11 | 2017-09-19 | 杭州逸曜信息技术有限公司 | Medical information processing method |
| CN107341345A (en) * | 2017-06-22 | 2017-11-10 | 厦门大学 | A kind of clinical rational drug use methods of risk assessment based on electronic health record big data |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109065118A (en) * | 2018-09-26 | 2018-12-21 | 平安科技（深圳）有限公司 | A kind of medical data processing method, device, terminal and readable storage medium storing program for executing |
| CN112116976A (en) * | 2019-06-20 | 2020-12-22 | 上海智臻智能网络科技股份有限公司 | Method and device for processing medicine information and computer readable storage medium |
| CN110767320A (en) * | 2019-10-31 | 2020-02-07 | 北京东软望海科技有限公司 | Data processing method and device, electronic equipment and readable storage medium |
| CN112164441A (en) * | 2020-10-07 | 2021-01-01 | 上海常笑健康咨询服务有限公司 | Internet-based online real-time total parenteral nutrition prescription rationality optimization system |
| CN112164441B (en) * | 2020-10-07 | 2022-09-27 | 上海常笑健康咨询服务有限公司 | Internet-based online real-time total parenteral nutrition prescription rationality optimization system |
| CN113012782A (en) * | 2021-03-05 | 2021-06-22 | 中国医学科学院阜外医院 | Method and device for recommending medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108447568A (en) | Medication information processing method based on drug ingredient | |
| Fletcher et al. | Failure of estrogen plus progestin therapy for prevention | |
| Pigeot et al. | Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations | |
| Christensen et al. | Assessing compliance to antihypertensive medications using computer-based pharmacy records | |
| Lutge et al. | The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS | |
| CN108447536A (en) | Medication information processing method based on genius morbi and disease degree information | |
| CN106407662A (en) | Medication information processing method based on warning information | |
| US20160042134A1 (en) | Method of calculating a score of a medical suggestion as a support in medical decision making | |
| CN106383993B (en) | The processing method of medical information | |
| Kristina et al. | Extemporaneous compounding practice by pharmacists: a systematic review | |
| Carney | Medication accuracy and general practitioner referral letters | |
| US20030144883A1 (en) | Method for analyzing side effects and interactions of pharmaceuticals | |
| CN106372430A (en) | Method for processing therapeutic scheme information | |
| Astrand et al. | The Swedish national pharmacy register | |
| Ali et al. | [Retracted] Amodiaquine‐Artesunate versus Artemether‐Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes | |
| CN106971083A (en) | Medication information processing method based on test rating | |
| CN111261254A (en) | Method and equipment for generating prescription and medical advice data entry system | |
| Patel et al. | Polypharmacy and cardiovascular diseases: Consideration for older adults and women | |
| Bhowmick et al. | Prescription audit study from a tertiary care private hospital in Kolkata, India | |
| US9977864B2 (en) | Electronic health record system and method | |
| Smit et al. | The incidence of nausea in the absence of vomiting in patients receiving intravenous chemotherapy | |
| EP2339488A1 (en) | A system for analysis and report of drug interactions | |
| Wilson et al. | Computerized triage of pediatric patients: automated triage algorithms | |
| Sweet | Being a Caring Doctor may be bad for you | |
| Chaturvedi et al. | Hospital admissions for dental disorders in patients with severe mental illness in Southeast London: A register‐based cohort study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180824 |
|
| RJ01 | Rejection of invention patent application after publication |